Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.

1,217 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Engineered Protease-resistant Antibodies with Selectable Cell-killing Functions* (2013, background): “total levels of EGF receptor vary widely in human tumor samples and are not uniformamong different individuals (43)).”
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. (2014, methodology): “tumor EGFR expression in two groups of patients treated with radiation alone in a prospective trial.(4,19) Assessments with the same method yielded no such association in the this study (Appendix Figs A1 and A2).”
Repopulation of cancer cells during therapy: an important cause of treatment failure (2005, background): “High EGFR levels have also been correlated with poorer clinical outcomes following radiotherap”